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Abstract
Osteoporosis is a common disease characterized by low bone mass, decreased bone quality and increased
predisposition to fracture. Genetic factors have been implicated in its etiology; however, the specific genes related
to susceptibility to osteoporosis are not entirely known. To detect susceptibility genes for osteoporosis, we conducted a
genome-wide association study in Japanese using ,270,000 SNPs in 1,747 subjects (190 cases and 1,557 controls)
followed by multiple levels of replication of the association using a total of ,5,000 subjects (2,092 cases and 3,114
controls). Through these staged association studies followed by resequencing and linkage disequilibrium mapping, we
identified a single nucleotide polymorphism (SNP), rs7605378 associated with osteoporosis. (combined P=1.51 610
28,
odds ratio=1.25). This SNP is in a previously unknown gene on chromosome 2q33.1, FONG. FONG is predicted to
encode a 147 amino-acid protein with a formiminotransferase domain in its N-terminal (FTCD_N domain) and is
ubiquitously expressed in various tissues including bone. Our findings would give a new insight into osteoporosis
etiology and pathogenesis.
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Introduction
Osteoporosis (MIM166710) is one of the most common skeletal
diseases affecting more than 200 million individuals in the world.
Its prevalence is estimated to be increasing dramatically as
population ages [1]. Osteoporosis is characterized clinically by
reduced bone mass and compromised bone strength, leading to an
increased risk of fracture.
Osteoporosis is a polygenic disease; Both environmental and
genetic factors contribute to its etiology and pathogenesis [2]. To
understand its genetic factor, identification of its susceptibility gene(s)
is important. There are several experimental approaches to identify
susceptibility genes for osteoporosis. One is a candidate gene
approach. Genes relevant to bone metabolism and disease genes of
rare monogenic bone diseases are widely studied by this approach and
the association with osteoporosis has been reported in many genes;
however, only a few genes like those for estrogen receptor 1 (ESR1), a1
chain of type I collagen (COL1A1) and low-density lipoprotein 5
(LRP5) are replicated for their association [3–5], including large-scale
meta-analyses using different ethnic populations [6,7].
Another approach is a genome-wide association study (GWAS).
GWAS has a great power to detect genetic variants with less than
moderate effects [8,9]. Its notable advantage is a potential for
finding previously unknown susceptibility genes [10]. Recently,
several groups conducted GWAS and identified many loci
associated with susceptibility to osteoporosis mainly in Caucasian
[11–16]; however, the genetic contribution to osteoporosis is not
entirely known.
To uncover additional susceptibility gene(s) for osteoporosis, we
conducted a GWAS in Japanese followed by staged replication
studies. We found a SNP (rs7605378) on chromosome 2q33.1 that
showed significant association (P=1.51610
28) with susceptibility
to osteoporosis. The SNP is in a previously unknown gene, which
we named FONG.
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GWAS
To identify the causal SNPs associated with osteoporosis, we
used staged association method [17,18] (Fig. S1). As the first stage
of discovery (Discovery 1), we performed GWAS and genotyped
268,064 SNPs that covered 56% of common SNPs in Japanese, in
190 cases and in 1,557 controls registered in the BioBank Japan
(BBJ) [19]. After passing through the quality control (QC) filter
described in the Material and Method, we successfully obtained
genotyping data for 224,507 SNPs. The x
2 distributions for the
association tests across the tested SNPs showed a low possibility of
overall systematic bias (genomic inflation factor: lGC=1.02). We
further performed a principal component analysis (PCA) [20] for
the samples and found no evidence for population stratification
(Fig. 1A).
SNPs reported by previous GWASs
We checked our GWAS data for 94 SNPs in 45 genes reported
in previous GWAS on osteoporosis [6,12,14–16,21–24]. Twelve
SNPs in eight genes were included in our platform, successfully
genotyped and passed the QC filter (Table S1). Five SNPs among
them showed P values below 0.05. Three SNPs in the PLCL1 gene
[12] showed significant association after the Bonferroni correction
(P,4.17610
23=0.05/12).
Step-wise screening
As the second stage of discovery (Discovery 2), we selected 3,000
SNPs showing the smallest P values in Discovery 1 and genotyped
these SNPs in an independent set of subjects composed by 526
cases and 1,537 controls. We successfully obtained genotyping
data for 1,654 SNPs. Quantile-quantile plots revealed the presence
of a number of SNPs associated with osteoporosis (Fig. 1B). The x
2
distributions for the association tests across the tested SNPs
showed a low possibility of false positive association due to
population stratification (lGC=1.04).
After the Discovery stages, no SNP exceeded the genome-wide
significance threshold. We therefore selected three SNPs that
showed the smallest P values (P,1.0610
23 in Discovery 2) for the
replication. In the discovery stages, there were age and sex
differences between the cases and controls. Therefore, to exclude
the false positive due to the differences, we used age- and sex-
adjusted cases and controls in the replication stages (Table S2). As
the first stage of replication (Replication 1), we genotyped the
SNPs in an independent set of female subjects composed by 1,326
cases and 1,292 controls. We set significance threshold in this stage
after the Bonferroni correction for multiple testing to
P,1.67610
22 (=0.05/3). Only one SNP, rs7605378 on chro-
mosome 2q33.1 showed significance (P=2.99610
23) (Table 1).
To validate the association of rs7605378, we further genotyped it
in an independent female population of 240 cases and 285 controls
as the second stage of replication (Replication 2), and found
further replication of the significant association (P=3.97610
22)
(Table 1).
Thus, through the staged association study using independent
populations, we identified and validated the association of
rs7605378, a new susceptibility loci for osteoporosis. The
combined P value was 1.51610
28 (OR=1.25; 95% CI: 1.16–
1.35) (Table 1).
LD mapping
To define the linkage disequilibrium (LD) block containing
rs7605378, we examine SNPs around rs7605378 (Fig. 2). We
referenced the International HapMap Project database (release
23a) and selected SNPs that had D’ value of .0.8 to rs7605378
and a minor allele frequency of .0.1. The LD block around
rs7605378 contained 51 HapMap SNPs and one hypothetical
gene, LOC348751. Next, we selected tag SNPs including
rs7605378 that covered all 51 SNPs with an r
2 value of .0.8.
After genotyping the 14 tag SNPs for 2,042 cases (Discovery 1, 2
and Replication 1) and 1,292 controls (Replication 1), we found no
more significantly associated SNP than rs7605378 (Table 2).
Then, we analyzed haplotype association using the 14 tag SNPs
for the LD block. We did not find any haplotypes that had more
significant association than rs7605378 (Table 3).
Identification of FONG
In the NCBI genome database (build 36.3), rs7605378 lay
within a hypothetical gene, LOC348751. Because the LOC348751
transcript was based on in silico predictions and expressed sequence
Figure 1. Evaluation of population stratification for the GWAS.
(A) Principal component analysis. Samples in the GWAS and in HapMap
database are analyzed by a program, Smartpca [20], and plotted for the
first (X axis) and the second (Y axis) principal components (PCs),
respectively. Our case and control samples are plotted in a single cluster
of Japanese. (B) Quantile-quantile (Q-Q) plots of allelic association using
Fisher’s exact (allelic) test in Discovery 2. Under the null hypothesis of
no association at any locus, the points would be expected to follow the
slope line (light green). Deviations of the points (red dots) from the line
correspond to loci that deviate from the null hypothesis. The genetic
inflation factor lambda is 1.04.
doi:10.1371/journal.pone.0019641.g001
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Population Number of subject RAF P value
a OR (95% CI)
b Phet
c
Case Control Case Control
Discovery 1 190 1557 0.647 0.556 7.11610
24 1.46 (1.17–1.83)
Discovery 2 523 1537 0.599 0.542 1.16610
23 1.27 (1.10–1.46)
Replication 1 1326 1292 0.564 0.524 2.99610
23 1.18 (1.06–1.31)
Replication 2 240 285 0.600 0.537 3.97610
22 1.29 (1.01–1.65)
All combined
d 2279 4671 1.51610
28 1.25 (1.16–1.35) 0.37
RAF: risk allele frequency, OR: odds ratio, CI: confidence interval.
aP values are calculated using the Pearson’s x
2 test for the allele model.
bOR of the risk allele from the two-by-two allele frequency table.
cHeterogeneity is calculated using the Mantel-Haenszel method.
dThe combined P value of the four studies (Discovery 1, 2 and Replication 1, 2) is calculated using the Mantel-Haenszel method.
doi:10.1371/journal.pone.0019641.t001
Figure 2. Association signals around rs7605378 on chromosome 2 in the GWAS stage. (A) LD plot for the studied region based on the r
2
statistic. The intensity of shading is proportional to r
2. (B) Genomic structure around the FONG region. (C) Results of GWAS for osteoporosis in a
Japanese population. The log10-transformed P values are plotted on the y axis.
doi:10.1371/journal.pone.0019641.g002
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expressed transcript from bone by RACE and RT-PCR. We
identified a new transcript that overlapped with, but was different
from LOC348751. The longest transcript was 1,997 bp in length
with a predicted protein of 147 amino acids (Fig. 3). A protein motif
analysis program (http://www.ebi.ac.uk/Tools/InterProScan/)
predicted that this protein contained a signal peptide and a
formiminotransferase domain in its N-terminal (FTCD_N domain).
We named this newly identified gene FONG (for formiminotransfer-
ase N-terminal sub-domain containing gene: AB568489). FONG
had many alternative splicing variants and multiple transcription
start sites (TSSs). We performed luciferase assays in two human
osteoblastic cell lines, MG-63 and SaOS-2, and confirmed that the
region containing 500-bp upstream of the major TSS and 59UTR
possessed promoter activity (data not shown).
Expression of FONG
To confirm the expression and size of the FONG transcript, we
carried out Northern analysis and identified two transcripts,
approximately 2.2 kb and 2.0 kb in length. The 2.0-kb transcript
was common to all tissues examined (Fig. 4A). We also examined
FONG expression in various human tissues using real-time PCR.
FONG was ubiquitously expressed in various tissues including bone
(Fig. 4B).
Determination of the most associated SNP
To locate the functional, osteoporosis-associated SNP, we
searched for SNPs in ,25 kb region that had r
2.0.8 with
rs7605378 by direct sequencing of genomic DNA from 24 case
subjects. We found 20 previously unknown SNPs in addition to 39
known SNPs in the HapMap database (Table S3). After
calculating pairwise r
2 values for all 59 SNPs in this region, we
selected 22 tag SNPs with r
2.0.95. In addition to the six SNPs
already genotyped, we selected 16 additional SNPs and genotyped
them for 697 cases (a part of Replication 1) and 567 controls (a
part of Replication 1). Two SNPs (SNP11 and rs58319901)
showed more significant association than rs7605378 (Table S4).
We genotyped them in additional samples consisting of 2,042 cases
(Discovery 1, 2 and Replication 1) and 1,292 controls (Replication
1); however, both SNP did not show more significant association
than rs7605378 (Table S5). In the ,25 kb region that had r
2.0.8
with rs7605378, we found 12 SNPs were in perfect LD (r
2=1) with
rs7605378 (Table S3). Because they were all in perfect LD with
each other, we could not pinpoint a candidate causal SNP among
these 13 SNPs.
Discussion
We have used a staged association design that provides
multiple levels of replication followed by resequencing of the LD
block, and identified a SNP, rs7605378 that is associated with
susceptibility to osteoporosis. Only a few osteoporosis GWAS
have been reported in Asian, which have identified a few specific
genes like JAG1 and ALDH7A1 [16,24]. This study represents the
first GWAS of osteoporosis in Japanese. In the discovery stages
(Discovery 1 and 2), there were age and sex differences between
cases and controls. However, the allele frequency of rs7605378 in
the stages was not significantly different between males and
females (P=0.33). We re-evaluated the association of rs7605378
in the stages by adjusted sex (female-only analysis). Because of
the decreased number of samples, the combined P value of
rs7605378 in the discovery stages became a little high, but their
ORs are similar after adjustment (with males: 1.32; female only:
1.34). In addition, we adjusted the age of the female samples by a
logistic regression and found no significant change in the ORs.
Therefore, we considered age and sex difference between cases
and controls did not confound the association. rs7605378
exceeds definite genome-wide significance level even after
Bonferroni correction, which is known to be very conservative.
Table 2. Association of 14 selected tag SNPs for the
rs7605378 region with osteoporosis.
SNP
Number of
subject MAF P value
a OR (95% CI)
b
Case Control Case Control
rs12373788 2036 1290 0.131 0.137 4.70610
21 1.05 (0.91–1.22)
rs7572473 2039 1292 0.314 0.276 9.54610
24 0.83 (0.75–0.93)
rs12615435 2039 1289 0.222 0.201 3.96610
22 0.88 (0.78–0.99)
rs10931875 2038 1290 0.300 0.296 7.49610
21 0.98 (0.88–1.09)
rs12473679 2038 1290 0.481 0.438 6.59610
24 0.84 (0.76–0.93)
rs6759644 2039 1290 0.076 0.095 6.04610
23 1.28 (1.07–1.52)
rs17529497 2038 1292 0.280 0.318 7.70610
24 1.20 (1.08–1.34)
rs6743271 2034 1289 0.442 0.417 4.42610
22 0.90 (0.82–1.00)
rs4673491 2037 1290 0.083 0.074 1.50610
21 0.87 (0.73–1.05)
rs7605378 2038 1292 0.419 0.476 3.96610
26 1.26 (1.14–1.39)
rs2030653 2036 1290 0.218 0.204 1.75610
21 0.92 (0.81–1.04)
rs2164889 2039 1292 0.207 0.190 9.22610
22 0.90 (0.79–1.02)
rs12470986 2039 1289 0.183 0.158 9.14610
23 0.83 (0.73–0.96)
rs10203122 2038 1290 0.389 0.347 4.84610
24 0.83 (0.75–0.92)
MAF: minor allele frequency, OR: odds ratio, CI: confidence interval.
aP values are calculated using the Pearson’s x
2 test for the allele model.
bORs are for the major allele versus the minor allele.
doi:10.1371/journal.pone.0019641.t002
Table 3. Haplotype association analysis using 14 tag SNPs in
the LD block containing rs7605378.
Haplotype
* Frequency P value OR (95% CI)
Case Control
22222212212222 0.241 0.274 6.17610
23 1.19 (1.05–1.35)
22111221222121 0.176 0.163 2.29610
21 0.91 (0.79–1.06)
21221221222211 0.150 0.122 3.33610
23 0.79 (0.67–0.93)
21222222221222 0.096 0.105 3.26610
21 1.10 (0.91–1.31)
12222222121222 0.063 0.053 1.35610
21 0.84 (0.66–1.06)
22222222212222 0.050 0.053 6.62610
21 1.06 (0.83–1.35)
12211121212222 0.045 0.058 3.33610
22 1.30 (1.02–1.67)
22211121212222 0.029 0.032 4.97610
21 1.11 (0.81–1.52)
22222212221211 0.018 0.018 9.40610
21 0.98 (0.65–1.48)
22111222212222 0.016 0.012 2.44610
21 0.75 (0.47–1.20)
21221222212222 0.015 0.009 7.59610
22 0.64 (0.39–1.08)
21221212212222 0.011 0.005 1.55610
22 0.46 (0.24–0.88)
All haplotypes with a frequency of .1% in the osteoporosis population of set 3
(case 3, control 3) are shown.
1 and 2 indicate the minor and major allele in the population, respectively.
OR: odds ratio, CI: confidence interval.
*The alleles of 14 SNPs (from left to right, rs12373788, rs7572473, rs12615435,
rs10931875, rs12473679, rs6759644, rs17529497, rs6743271, rs4673491,
rs7605378, rs2030653, rs2164889, rs12470986 and rs10203122) are shown.
doi:10.1371/journal.pone.0019641.t003
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ledge, this is the first report of a novel gene as a susceptibility
gene of osteoporosis.
Comparison of our GWAS data with SNPs identified in
previous GWASs on osteoporosis [6,12,14–16,21–24] showed five
SNPs in three genes (PLCL1, DOK6, and MEF2C) with P values
below 0.05 (Table S1). These results in Japanese, a different ethnic
population from the previous studies would support their
association. We could not deny the association of other promising
SNPs identified in previous GWASs, because our GWAS has a
limited power to detect association due to the relatively small
sample size and moderate coverage of the genome. Ethnic
difference in genetic background may also preclude replication
of these SNPs; some SNPs identified in previous GWAS in
Caucasians are found monomorphic in Japanese in the present
study. Three SNPs in PLCL1 showed significant association even
after correction of the multiple testing in our study (Table S1).
However, whether these results really support the association of
PLCL1 is not clear, because their allele frequencies had not been
disclosed in the previous study [12] and hence the direction of the
association of these SNPs (i.e., which alleles were the susceptibility
alleles) remains unknown.
Figure 3. Nucleotide and deduced amino acid sequences of FONG. A domain homologous to the FTCD_N domain is underlined. A stop
codon is indicated by an asterisk, and the putative poly-A addition signal is enclosed in an open box. Multiple transcription start sites (TSSs) were
identified by 59-RACE, but only the major TSS is shown.
doi:10.1371/journal.pone.0019641.g003
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19641In the current public databases, rs7605378 was located in
LOC348751, a hypothetical gene based on in silico prediction. In the
prediction, LOC348751 consists of 5 exons; however, our RT-PCR
experiments could only prove a part of exon 2 and exons 3–5. The
predicted exon 1 was not present. Therefore, we performed the 59-
and 39-RACE using bone cDNA and determined the actual mRNA
sequence and the gene structure. We found that FONG consisted of 4
exons;the exon 1 and a part of exon 2 of LOC348751 were not present
(Fig. S2). In addition, FONG had many splicing variants. Most of the
variants contained exons 2 and 3 of FONG in common, but the first
and last exons had variants. The new transcript that we have found
(Fig. 3) existed in several tissues like kidney, skeletal muscle, liver and
bone (Fig. 4A) and its predicted protein sequence was conserved
among several species. Therefore, we think the transcript that we have
found (Fig. 3) is a major splicing variant of FONG.
The N-terminal amino acid sequences of FONG corresponding
to the FTCD-N domain are highly conserved from Xenopus to
human, suggesting its important biological role. FTCD is a
mammalian metabolic enzyme which involves in conversion of
histidine to glutamic acid, and the FTCD-N domain has a
transferase activity that transfers a formimino group from N-
formimino-L-glutamic acid to tetrahydrofolate to generate gluta-
mic acid and 5-formiminotetrahydrofolate [25]. The glutamate
signaling is considered to play an important role in bone
homeostasis. For instance, L-glutamic acid is known to be secreted
by osteoclasts and knockout mice of the glutamate transporter 1
develop osteoporosis [26]. These lines of evidence suggest that
FONG have a potential to regulate bone metabolism.
While preparing this paper, annotation of LOC348751 in public
database is updated and LOC348751 has come to be described as a
miscRNA. However, the length of the LOC348751 mRNA in the
database (NR_034096.1) is shorter than that of the FONG mRNA
that we experimentally determined. The new LOC348751 mRNA
consisted of 966 bp and its open reading frame (ORF) encoded
only 77 amino acid residues, while the FONG mRNA consisted of
1,997 bp and its ORF encoded 147 amino acids. Besides, the
protein sequence of FONG is well conserved between different
species. We suspect that LOC348751 is one of the FONG variant
transcripts. However, because we have not yet succeeded in
proving the existence of the FONG protein experimentally, we
cannot deny the possibility that FONG functions as a miscRNA.
Recently, many miscRNAs are found and their important roles in
pathogenesis of diseases have been known [27–29].
The most associated SNP, rs7605378, is in perfect LD with 12
SNPs (Table S3). All of them are in the FONG region, but they do not
cause amino acid substitutions. These SNPs are located in intron 3 or
39 flanking region. Therefore, they may have affect FONG expression.
Two ESTs containing rs7605378 are reported. In our experiments,
we could not find any FONG splicing variant(s) containing these
ESTs. However, some splicing variants seems tissue specific and
FONG may have other splicing valiant(s). Further analysis of these
transcripts may provide a new insight into FONG function.
In conclusion, this study identified a previous unknown gene,
FONG as a novel susceptibility gene for osteoporosis. Although
FONG function and its osteoporosis-causing mechanism are largely
unknown, our findings would provide a new insight into the
complex geneticarchitectureofosteoporosis.Theidentified variants
are warranted by further biological and clinical investigation.
Materials and Methods
Subjects
We carried out a stepwise case-control association method as
previously described [10,30–32], using several independent
populations (Table S2). Case and control subjects used in
discovery stages were obtained from the BBJ [19]. Osteoporosis
was diagnosed according to the criteria of Japanese Osteoporosis
Society as bone mineral density (BMD) being ,70% of young
adult mean (YAM) at either the lumbar spine or femoral neck [33].
This criteria is equivalent to that of the World Health
Organization (WHO) of T-score,22.5. BMD at the lumbar
spine (L2-4 or L1-4) and/or femoral neck was measured by dual
energy radiograph absorptiometry with standard protocols. All
individuals in the osteoporosis populations were postmenopausal
and/or over 60 years female. The controls were the subjects with
various diseases other than osteoporosis as previously described
[19]. For the replication study, the criteria of cases are same as the
discovery stage and that of controls are postmenopausal females
and/or females over 60 years. The cases in Replication 1 were also
obtained from BBJ. The cases in Replication 2 and the controls in
Replication 1 and 2 were obtained from unrelated ambulatory
Figure 4. Tissue expression of FONG. (A) Northern blotting in
human tissues. Lane 1, kidney; lane 2, skeletal muscle; lane 3, liver; lane
4, bone. (B) Quantitative real-time PCR in various human tissues. FONG
is highly expressed in liver, skeletal muscle, and moderately expressed
in bone. Data represent the mean ratios of FONG mRNA to b-actin
(ACTB) mRNA 6 s.e.m. of two independent experiments.
doi:10.1371/journal.pone.0019641.g004
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19641volunteers. All the participants provided written informed consent.
This research project was approved by the ethical committees at
Institute of Medical Science, the University of Tokyo and Center
for Genomic Medicine, RIKEN.
SNP genotyping
Using standard protocols, genomic DNA was extracted from
peripheral blood leukocytes. In Discovery 1, 268,064 SNPs from
autosomal chromosomes were genotyped by using high-density
oligonucleotide arrays (Perlegen Sciences). These SNPs were selected
from JSNP [34] or HapMap database [35] as tagging SNPs for
Japanese. SNPs having call rate .90% and no significant deviation
from Hardy-Weinberg equilibrium (HWE; P$1.0610
26) were used
for the analysis of association. A total of 224,507 SNPs were passed
QC filters and werefurther analyzed for their association.Among the
SNPsanalyzedinDiscovery1,top3,000SNPsshowingthesmallestP
values were selected for Discovery 2. Genotyping of Discovery 2 was
conducted using the multiplex-PCR invader assay [36] or high-
density oligonucleotide arrays (Perlegen Sciences). In this stage, 1,654
SNPs passed QC filters (call rate of $0.9, P value of HWE$0.01 in
controls, and concordance rates of .90% between Perlegen and
Invader assays using randomly selected 94 case samples and 752
control samples). Among the SNPs analyzed in the discovery stages,
top three SNPs showing the smallest P values were selected for the
replication study in the replication stage. Genotyping in the stage was
conducted using the multiplex-PCR invader assay or the TaqMan
assay (Applied Biosystems). All cluster plots were checked by visual
inspection and SNPs with ambiguous calls were excluded.
Statistical analysis
In the discovery stage, Fisher’s exact test was applied to two-by-
two contingency table in three genetic models: an allele frequency
model, a dominant-effect model, and a recessive-effect model. At
the replication stage, the association was assessed using x
2 test that
was applied to two-by-two contingency table in the three genetic
models. Odds ratios and confidence intervals were calculated using
the minor allele as a reference. The haplotype association was
analyzed using Haploview software [37]. A PCA was conducted to
detect population stratification [20]. A combined P value and
heterogeneity were calculated using the Mantel-Haenszel method.
RACE, RT-PCR and real-time PCR
59- and 39- RACE were performed using Marathon-Ready
cDNAs for human kidney, skeletal muscle and liver (Clontech). A
human bone cDNA library was constructed using FastTrack 2.0
mRNA Isolation kit (Invitrogen) and SMART RACE cDNA
amplification kit (Clontech) according to the manufacture’s
protocol. A bone cDNA was synthesized using Multiscribe reverse
transcriptase and a random hexamer primer (Applied Biosystems).
The bone cDNA and multiple tissue cDNA panels (Clontech) were
used for PCR experiments to examine tissue-specific expression of
FONG. Quantitative real-time PCR was carried out using an ABI
PRISM 7700 sequence detector with Quantitect SYBR Green
PCR Kit (Qiagen) in accordance with the manufacturers’
instructions.
Northern blotting
The cDNA fragment corresponding to nucleotides 413–731 of
FONG was cloned into the pCR2.1 TOPO vector (Invitrogen).
The DIG-labeled probe was synthesized from the constructed
vector using DIG RNA Labeling Kit (Roche). Total RNAs of
kidney, skeletal muscle and liver were purchased from Clontech
(The skeletal muscle: seven male/female Caucasians, kidney: 14
male/female Caucasians, liver: a male Caucasian). Total RNAs of
bone was extracted from bone tissues of nine male/female
Japanese. mRNAs were synthesized using FastTrack 2.0 mRNA
Isolation kit (Invitrogen) and 2 mg of mRNAs were used for gel
electrophoresis. Transfer, hybridization and detection were done
using DIG Easy Hyb and DIG Wash and Block Buffer set (Roche)
according to the manufacturer’s instructions.
Supporting Information
Figure S1 Design of our staged association study. We
performed a genome-wide screening as the first stage of discovery
(Discovery 1), followed by further examination of the top findings
(Discovery 2). We then performed two replications (Replication 1
and 2) and resequencing of the LD block. In each stage, we
consider the minimum P value in three genetic models.
(TIF)
Figure S2 A schematic diagram of the gene structures of
FONG and LOC348751. Boxes indicated exons. All exon-intron
junctions conformed to the ‘‘ag-gt’’ rule. The open boxes represent
the untranslated regions and the closed boxes the coding regions.
The reading frames of FONG and LOC348751 are different.
(TIF)
Table S1 Comparison of the previous GWAS and the
current GWAS.
(XLS)
Table S2 Basal characteristics of the subjects.
(XLS)
Table S3 SNPs in the same linkage disequilibrium
block (r
2.0.8) with rs7605378.
(XLS)
Table S4 Association of additional tag SNPs in FONG
region with osteoporosis.
(XLS)
Table S5 Association of rs7605378, SNP11 and rs-
58319901 with osteoporosis.
(XLS)
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